Here we demonstrated that a single‐dose treatment of AAV‐D7 after individually defined disease onset improved life span and motor activity in ALS mice, although the mechanisms by which DOK7 gene therapy suppresses denervation at the NMJ, and disease progression in ALS, remain to be established. This evidence concerns the gene DOK7 and amyotrophic lateral sclerosis.